High Vero Cell Density and Rabies Virus Proliferation on Fibracel Disks Versus Cytodex-1 in Spinner Flask
S. Mehdi Hassanzadeh,
M. Ali Shokrgozar,
To achieve higher titer of rabies virus higher density of host cells will need. In this study, capability of FibraCel disks packed in 500 mL spinner basket versus Cytodex-1 in 500 mL spinner flask was investigated for propagation of Vero cells and PV rabies virus proliferation. Minimal Essential Medium (MEM) + 10% Foetal Calf Serum (FCS) and Virus Production- Serum Free Medium (VP-SFM) + 4 mM L-glutamine were used in growth phase and MEM+ 0.2% Bovine Serum Albumin (BSA) and VP-SFM were used in virus production phase. Adapted Vero cells grown in VP-SFM were used in all SFM experiments while batch and stepwise perfusion modes were applied and compared in growth stage. The highest Vero cell density were achieved in the trials with 10 g FibraCel disk in stepwise perfusion mode equal to 6.12x106 and 5.87x106 cells mL-1 in MEM and VP-SFM, respectively while with 2.73 g Cytodex-1 lower density equal to 4.2x106 and 4.0x106 cells mL-1 were achieved. The highest titer of rabies virus and overall virus production rate were resulted in VP-SFM and on 10 g disks equal to 2.9x107 Fluorescent Focus Unit (FFU) mL-1 and 0.14 FFU/Cell/h, respectively versus 1.7x107 FFU mL-1 and 0.08 FFU/cell/h on cytodex-1 in similar conditions. The second harvest of virus was also satisfactory in experiment with 10 g disks (1.7x107 FFU mL-1) in compare to Cytodex-1 (0.51x107 FFU mL-1). An equal surface area at 6600 and 12000 cm-2 were provided in all comparable trials with seeding density of 12.5x103cells cm-2. Adapted Vero cells grown in VP-SFM were used in all SFM experiments while batch and stepwise perfusion modes were applied and compared in growth stage.
January 15, 2011; Accepted: June 01, 2011;
Published: July 13, 2011
Rabies has a long story as a fatal disease of the nervous system of mammals
that cause by rabies virus and rabies vaccine is known as the only way to prevent
human death due to rabies. Rabies occurs in more than 100 countries and territories
with 55,000 annual deaths around the world and continues to be one of the major
public health hazards in many developing countries (WHO,
2010; Knobel et al., 2005; Meslin
et al., 1994; Martinzn, 2000; Nandi
and Kumar, 2011). Although the efficacy and safety of modern cell culture
vaccines have been recognized but some countries are still producing and using
nervous tissue vaccines which are less effective and have the disadvantages
of causing sever adverse reactions. Global programs to control rabies as the
goal of WHO and investigation in field of economic production of safe rabies
vaccine are being continued specially in infected developing countries (WHO,
2007; Rourou et al., 2009; Jagannathan
et al., 2009).
The attachment-dependent cell (ADC) line that was first initiated and developed
from a normal adult African velvet monkey (Cercopithecus aethiops) kidney
tissue by Yasumura and Kawakita (1963) of Chiba University
of Japan was named Vero. it has been demonstrated that low-passage number Vero
is not presenting any threat to human health when used as a substrate for biological
production authorized by WHO such as vaccines (Horaud, 1992;
Montagnon et al., 1999; Vincent-Falquest
et al., 1989). Vaccines produced by Vero cells are also more efficient
and safer than animal nervous tissue culture and would be more economic than
using human diploid cell strains such as MRC-5 (Kumar et
al., 2002). Although, adapting Vero cells to grow as a free-cell suspension
has reported by Paillet et al. (2009) and Daelli
(2007) but Vero cells are still known as an attachment-dependent cell line
and therefore, absolutely requires high volumetric surface area to reach higher
volumetric cell yields (Mendonca et al., 1993).
|| Characteristics of the carriers used for propagation of Vero
cells and rabies virus
The vaccine industry is rapidly moving away from traditional egg-based production
to more rapid and cost-effective cell-based techniques. Microcarriers such as
Cytodex for many years and newly Fibra-Cel disks are being used for suspension
culture of bonded Vero cells. FibraCel made by New Brunswick Scientific (NBS)
introduced in the early 1990s, have been in use for nearly two decades throughout
the world for research and production. Fibra-Cel disks as a solid-support matrix
provide an extremely high-surface area for growth of attachment-dependent cells
designed for animal and insect cells, predominantly used for production of secreted
products such as recombinant proteins and viruses. These disks composed of polyester
non-woven fiber and polypropylene; treated electro statically to facilitate
suspension cells adhering to the disks and becoming trapped in the fiber system
(Table 1). The advantages and benefits of FibraCel disks over
standard micro carrier technology would be: Low pressure drop across the bed,
High surface-to-volume ratios, Less susceptibility of immobilized cells within
the disks to shear forces from impeller blades and sparger gas bubbles, Higher
mass transfer of nutrients and oxygen, Easy and efficient separation of biomass
from secreted products (New Brunswick Scientific, 2006;
De Oliveira Souza et al., 2005; Vyas
and Cino, 2005).
Fibra-Cel disk as a porous macro carrier is being used in 0.5 to 300 L in form
of packed-bed bioreactor, disposable bags, spinner and suspension culture that
enhance the surface area available for attachment and multiplication of ADC
such as Vero cells (Glaser and Bioreactor Fermentor Market
Classical cell culture vaccines commonly contained animal derived substances
such as Fetal Calf Serum (FCS) in their production processing. Serum with having
some essential nutrients and beneficial factors has properties of growth promoting
for cells in cultures (Hesse and Wagner, 2000). Notwithstanding
remarkable usefulness, using serum has also some disadvantages (Fishbein
et al., 1993; Lubiniecki, 1999). Laboratories,
for standardization of media composition and among some industrial-scale production
units to facilitate downstream processing and reduce the risk of adventitious
infectious agents, now prefer using serum-free media (Merten,
2000) although serum-free media are also not without disadvantages (Freshney,
2005). VP-SFM (Gibco) is a commercial Serum Free Media that is suitable
for growth of Vero cells and producing virus such as rabies virus (Frazatti-Gallina
et al., 2001).
Although rabies virus production by Vero cells grown in Serum Contained Media
(SCM) and SFM were already repeatedly reported on micro carriers such as Cytodex-1
(Merten et al., 1999; Frazatti-Gallina
et al., 2004) but there is not much data for production of rabies
virus by Vero cells grown on disks.
In this study a laboratory investigation was presented in potential of FibraCel disks over against Cytodex-1 microcarriers in an equal surface area and in volume of 500 mL for cultivating of Vero cells and PV rabies virus production by the use of fed batch and stepwise perfusion modes in SCM and SFM.
MATERIALS AND METHODS
Cell line: Vero cells were obtained from cell bank of Pasteur Institute of Iran.
Virus strain: Fixed strain of Pasteur rabies Virus (PV) adapted to grow on Vero cells was prepared by WHO- collaborating and research rabies center of Pasteur Institute of Iran.
Sequential adaptation of vero cells to vp-sfm: This is Invitrogens
preferred method for adapting cells to Serum-Free Media (SFM), with a typical
conversion being. In mid-logarithmic phase Vero cells (3.5x105 mL-1)
were first cultured in 75% serum contained MEM + 25% SFM in a 25 cm-2
T-flask at 37°C, 5% CO2. When cell density reached to 2x106
mL-1, they were subculture by density of 3x105 cells
mL-1 in 50% SCM + 50% SFM again. The cultures of cells to being adapted
were subcultured every 4 days for more 2 times with reduction of SCM to 25 and
10% and replacing the SFM. Cells were fully adapted when reach to 3x106
mL-1 with more than 90% viability in SFM. As described by Rourou
et al. (2007) working cell bank of adapted Vero cells was established.
Culture media and supplements: Fetal Calf serum and VP-SFM (Cat# 12559-019)
were supplied by Invitrogen (Glasgow, UK).
|| Vero cells growth, rabies virus production and culture characteristics
in the various trials
Lactate assay kit (Cat# k627-100) and Glucose assay kit (Cat # k606-100) were
brought by BioVision (CA 94043 USA), Ammonia assay kit, MEM, non amino acids
solution and all other chemicals were obtained from Sigma (St. Louis, USA).
Microcarrier preparation: Cytodex-1 was sterilized in Phosphate Buffer Saline (PBS) prior transfer into stirrer flasks according to manufacture instruction.
Fibra-cel disks preparation: Spinner basket was loaded with defined amount of Fibra-Cel disks using analytical balance and laminar air flow cabinet to minimize germ particles then was filled with appropriate volume of sterile PBS and autoclaved prior usage.
Preparation of cells in spinner cultures: MEM supplemented with 10% FCS and VP-SFM + 4 mM l-glutamine were used in SCM and SFM experiments, respectively.
Spinner basket containing FibraCel disks and PBS was initially autoclaved then PBS was replaced aseptically with 400 mL of supplemented media. With the autoclaved spinner flask, PBS was replaced with 400 mL of supplemented media containing Cytodex-1 aseptically.
Propagated Vero cells in T-flasks in SCM and in VP-SFM at 37°C in 5% CO2
were treatment by trypsin and TrypLE Selec, t respectively as described by Rourou
et al. (2007). Dissociated cells were used as inoculants with seeding
density of 1.25x104 cell cm-2. The final working volume
in cultivation chamber adjusted 500 mL and headspace was inspired by 5% CO2
atmosphere using an aquarium pump at 37°C incubator. Stirring speed was
set at 25 rpm in beginning then continued at 40 rpm during cell growth and kept
constant during sampling of stirrer flask to ensure a representative sampling.
Level of glucose and pH was measured and adjusted daily by adding of glucose (260 g L-1) and NaHCO3 (88 g L-1) if necessary. In stepwise perfusion (draw-and-fill) mode, adjusting glucose and lactate concentration at suitable levels, was done by exchange of 75% of spent medium with an equal volume of fresh one daily at day 2 at rpm 0 in which microcarriers were allowed to settle. Large size of the disks (6 mm) helps the cell-free medium to be removed out from the spinner basket through a sterile tube by pumping. The pH 7.2 and glucose at not below 1g L-1 were daily fixed during propagation of cells. All experiments carried out triplicate as shown in Table 2.
Virus propagation phase: Once the high Vero cell density was achieved in each experiment (at day 4-9) media were removed completely then attached cells on carriers were washed two times by virus production medium (MEM + 0.2% BSA for serum contained and VP-SFM + 4 mM L-glutamine for serum free trials). After 3 h at 34°C, pH 7.4 and 5% CO2; conditions that stimulate penetration of virus, virus inoculants with a Multiplicity of Infection (MOI) of 0.3 were transferred into the flasks to infect Vero cells. Infection phase continued for 4 days by daily sampling and adjusting pH at 7.4.
Off-line metabolite analysis methods: Growth and infection indexes including viable cell density, titer of virus, pH and concentration of glucose, lactate and ammonia were measured by daily sampling and using specific assay kits.
Cell counting: To estimate periodically the viable cell population during
growth and infection phase, we used nuclei count method as described by Trabelsi
et al. (2005). To estimate and visualize viable cells and to confirm
cell density obtained already by nuclei count method during operation; defined
number of disks were treated with PBS, followed by using a standard trypsinization
buffer and incubation for 30 sec at 37°C, 5% CO2, then the liquid
was removed and 1 mL PBS was added and incubated at 37°C for 8 min (New
Brunswick Scientific, 2006; Vyas and Cino, 2005).
For detaching cells from cytodex-1 we followed standard trypsinization procedure
(Trabelsi et al., 2005). Detached cells were
stained by Trypan blue and counted by hemacytometer slide (Doyle
and Griffiths, 1998). Detached (suspended) cells in supernatant or free
space on Cytodex-1 microcarriers will show the density of dead cells.
Rabies virus titration: Virus titer was estimated according to a modified
Rapid Fluorescence Focus Inhibition Test (RFFIT) (Trabelsi
et al., 2006; Smith et al., 1973) and
expressed in Fluorescent Focus Units per mL (FFU mL-1).
The overall virus productivity rate (vpr) was calculated as follows:
where, C is the virus titer in FFU mL-1 obtained at the end of the
culture. Xinfection and Xend stand for cell density level
at the time of infection and at the end of the culture, respectively. Infection
period corresponds to the duration of the virus production phase in hours. Also
monitoring of infected cells was done every day post infection based on count
of carriers-attached viable cells and suspended dead cells. Also microscopic
examination method was used to visualize infected cells. Trypsinized cells were
dried on a microscopic slide and fixed by cold 80% acetone. Fixed cells then
stained with fluorescein-labeled antibodies nucleocapsid immunoglobulins (Sanofi
Diagnostic Pasteur, Marnes la Coquette, France, Cat. No. 72114).
In 12 trials (Table 2) a 500 mL spinner basket containing 5.5 and 10 g of Fibra-Cel disks versus a 500 mL spinner flask loaded with 1.5 and 2.75 g Cytodex-1 were used to evaluate Vero cells growth and rabies virus proliferation. The experiments were performed in batch and in stepwise perfusion mode for growth phase with initial inoculums of 1.25x104 cells cm-2 in SCM and VP-SFM, cells then reached at the highest density and were infected by PV strain ( MOI of 0.3 ) in MEM + 0.2% BSA and in VP-SFM + 4 mM l-glutamine in batch mode.
Vero cells growth and metabolite profile: As shown in Fig. 1 more than 99% of the Vero cells of initial inoculums became strongly immobilized in the disks rapidly, within approximately 85 and 120 min in MEM and VP-SFM, respectively while with Cytodex-1 it was estimated about 120 and 320 min.
Comparison of growth curve (Fig. 2) of adapted and non-adapted
Vero cells in VP-SFM in 25 cm-2 T-flask demonstrated that adapted
cells grow well in SFM comparable with cells grown on SCM.
The highest surface cell density in amount of 255x103 cells cm-2 (Fig. 3) and equal to 6.12x106 cells mL-1 (Fig. 4) were achieved in trial 11 on 10 g disk (12000 cm-2) and on SCM in stepwise perfusion mode during 8 days while in similar conditions on VP-SFM (trial 12) it was slightly lower in amount of 245x103 cells cm-2 (5.87x106 cells mL-1). By the use of 2.73 g Cytodex-1 (12000 cm-2) the highest cell density were estimated at 175x103 cells cm-2 (4.2x106 cells mL-1) and 167x103 cells cm-2 (4.0x106 cells mL-1) in SCM (trial 9) and SFM (trial 10), respectively. The lowest achieved surface cell density was seen in batch mode (trial 6) on 2.73 g Cytodex-1 in SFM equal to 130x103 cells cm-2 (3.11x106 cells mL-1) while with lower Cytodex-1 (trial 2) higher cell density in amount of 175x103 cells cm-2 was achieved.
||Vero cell adhesion to the FibraCel disk (FC) and Cytodex-1
(CX) during the 6 hours of culture in MEM+10%FCS and VP-SFM
||The curves of Vero cells growth on SCM and comparison with
adapted and non adapted Vero cells grown on SFM
||Evaluation of Vero cell density, Specific Growth Rate (SGR),
Glucose consumption, Lactate and Ammonia level achieved in batch (1-8) and
stepwise perfusion trials (9-12)
||Vero cell density and rabies virus titer achieved on FibraCel
disks in spinner basket and on Cytodex-1 in stirrer flask Batch (1-8), stepwise
perfusion (9-12), first rabies virus titer (9-12) and second titer (10,12)
The highest and lowest specific growth rates were seen in trials 3 and 12, respectively.
Profile of produced Lactate, ammonia and spent glucose resulting in the growth phase also were shown in Fig. 3. The higher concentration of lactate were resulted in batch trials with SFM in compare with SCM especially in trials with disks, the while ammonia appeared at higher level in trials with MEM.
The highest level of lactate equal to 69.43 mM was measured in trial 8 with 10g FibraCel disks and in SFM while in MEM and in similar conditions, 59.12 mM lactate resulted. In stepwise perfusion mode (trial 9-12), lactate and ammonia concentration reduced to the lowest levels as shown in Fig. 3.
Rabies virus production: Achieved rabies virus titers in the trials 9-12 is shown in Fig. 4. The highest virus concentration was achieved in trail 12 with 10 g disk and in stepwise mode. Also, cell density at the time of infection and at day 3 post infection were estimated in amount of 5.87x106 and 3.0x106 cells mL-1, initial and final titer of virus concentration equal to 0.18x107 and 2.9x107 FFU mL-1 and overall virus productivity at 0.14 FFU/Cell/h. In trial 11 in the same condition but on SCM, final virus concentration reached 2.1x107 FFU mL-1. In trial 10 with 2.73 g Cytodex-1 on VP-SFM, virus proliferation while cell density and titer of virus at day 3 post infection reached 1.1x106 cells mL-1 and 0.12 x107 FFU mL-1, respectively. The second harvests in trial 10 and 12 in which spent SFM at day 3 post infection was completely exchanged with fresh one and kept for 3 next days, titer of virus was 0.51x107 FFU mL-1 and 1.7x107 FFU mL-1 for Cytodex-1 and disks, respectively.
Comparing the adhesion, Vero cells mighty anchored to the FibraCel disks faster
than that occurred on Cytodex-1 that could be due to a safer situation for Vero
cells inside the porous disks in beginning of culture letting the cells to trap
and attach quickly on the inner fibers as well as their outer surface (negatively
charged). Surface cell density achieved in SCM batch experiments on 13.2 cm-2
mL-1 of Cytodex-1 and FibraCel disks were almost closed together
(±0.01 log). These results were also comparable with that obtained by
Trabelsi et al. (2005) equal to 212x103
cells cm-2 (2.8x106 cells mL-1). They used
Vero cells grown in MEM+10% FCS+0.2 mM Serine+0.2 mM methionine and 3 g L-1
Cytodex-1 (13.2 cm-2 mL-1) in 250 mL spinner flask. Present
results on VP-SFM (trial 2, 4) were a little less than those we achieved in
SCM and also those that has reported by Rourou et al.
(2007) equal to 227x103 cells cm-2 (2x106
cells mL-1) by the use of 2 g L-1 of Cytodex-1 in 250
mL spinner flask containing VP-SFM. Difference was bigger between trial 1 and
2 (±0.06 log) than between trial 3 and 4 (±0.01 log) and also
between trial 2 and 4 then between trial 1 and 3 that represent efficiency of
FibraCel disk when using SFM.
In increased volumetric available surface area (24 cm-2 mL-1),
achieved cell density on 10 g FibraCel disks were higher than those achieved
on 2.73 g Cytodex-1 but altogether a relatively decrease in specific growth
rate and surface cell density seen in trial 5-8 in compare to trials 1-4. These
results are almost in agreement with Trabelsi et al.
(2006) who reported a cell density equal to 212x103 cells cm-2
(2.22x106 cells mL-1) and 155x103 cells cm-2
(4.1x106 cells mL-1), respectively on 3 and 6 g L-1
Cytodex-1 in 250 mL spinner flasks. Relative decrement of surface cell
density with 2.73 g versus 1.5 g Cytodex-1 might be due to a more cell injury
in face to more collisions of beads and shear force in higher concentration
of microcarriers. This relative decrement with 10 g versus 5.5 g disk was lower
probably because of lower shear forces. Furthermore discrepancy between achieved
cell density levels on FibraCel disks in VP-SFM and in MEM was less sensible
than those achieved when using Cytodex-1. Apparently inside the porous disks,
cells safeness was better established than on the surface of Cytodex-1 in particular
when using SFM in which cells would be more sensitive to shear forces. Yokomizo
et al. (2004) described that macroporous microcarriers have the ability
to protect cells against detrimental hydrodynamic forces generated by collision
In stepwise perfusion mode cell density improved on FibraCel disks in higher
level than those obtained on Cytodex-1 and higher than those discussed above.
Mendonca and Periera (1995) reported a high cell density
comparable to present results and equal to 136,636 cells cm-2 (6.0x106cells
mL-1) on 10 g L-1 Cytodex-1 using perfusion culture mode.
Their result supported ours and indicates higher cell density could be achieved
with available higher surface. Specific growth rate shows a decrease in the
experiments with SFM and disk that is because of need to longer incubation time
to reach maximum cell density.
The fecundity of fed-batch mode will be limited while nutrients are being depleted
and toxic metabolites, mostly Lactate and ammonia arisen (Hinterkorner
et al., 2007; Wentz and Schiiger, 1992) more
than 20-30 mM and as low as 2-3 mM, respectively (Genari
et al., 1998; Hassell et al., 1991).
This is why a lesser cell density was achieved in the batch trials of this work.
In stepwise perfusion mode, we maintained glucose at 6-15 mM, lactate and ammonia
at non toxic level that resulting improvement in Vero cells fertility and specific
growth rate on disks more than on beads. Although, Quesney
et al. (2001) have mentioned lactate and ammonium ions did not reach
toxic levels in SFM for Vero cells it seems however in present of higher toxic
metabolites, cells on Cytodex-1 are more fragile in the face of harmfulness
whereas immobilized cells in packed disks would be in lesser danger of these
physical and chemical harms. Merten et al. (1994)
have showed that in Vero cells submitted to nutritional stress conditions, the
pattern of growth and adhesion will be altered. Growth inside the FibraCel disks
far from stress might be another reason of higher growth rate of Vero cells
seen with disks in this study.
In this study, the highest titer of rabies virus and overall virus productivity
was achieved on FibraCel disk. Also virus productivity of VP-SFM was higher
than MEM+ 0.2% BSA. We harvested the highest level of virus on 10 g FibraCel
disks and on SFM, about 0.2 log higher than that reached on 2.73 g Cytodex-1
with higher overall virus productivity rate in similar conditions. Count of
detached cells three days post infection indicated a higher reduction rate of
infected cells on Cytodex-1 probably due to more fragility of infected cells
in collisions of beads that could be considered as a reason for lesser virus
productivity. In this respect, second virus harvest from FibraCel disks was
higher than on Cytodex-1 because of lower rate of infected cell mortality. There
is no former report on rabies virus production by the use of Vero cells on FibraCel
disks Gumusderelioglu et al. (2001) have reported
production of rabies virus using BHK-An66 in 5 g L-1 non-woven polyester
fabric (NWPF) packed-bed reactor with virus titer of 2.2x105 FFU
mL-1. They also mentioned to NWPF packed reactors can be considered
as a suitable system for the large-scale production of rabies virus. Namdev
and Lio (2000) used FibraCel disks in a disposable-bag wave action system
to cultivate CHO cells for production of recombinant protein and have reported
that FibraCel disks are better option than Cytodex-3 and CultiSpher-S to support
cell growth with viability over a long time about 11 days.
This study showed that the level of Vero cells density and titer of rabies virus could reach higher on FibraCel disk than on equal surface area provided by Cytodex-1 in MEM and VP-SFM, in batch or stepwise perfusion mode either. Our results showed a good operational capability of FibraCel disk to use as an alternative solid support for Vero cells distinctively when using SFM.
This project was full financial supported by Pasteur Institute of Iran. We are grateful to Dr. Hela kallel in Pasteur Institute of Tunis for helping us with their laboratory facility and knowledge and we would like to thank N. Howaizi, A. Janani and P. Biglari of assistance with the laboratory techniques including virus titration and microscopic examination.
Daelli, M., 2007. Vero cell line which is adapted to grow in suspension, method of obtaining same and viral vaccines. WIPO, (WO/2007/039662). http://www.freepatentsonline.com/EP1942182.html.
De Oliveira Souza, M.C., M. da Silva Freire and L. dos Reis Castilho, 2005. Influence of culture conditions on vero cell propagation on non-porous microcarriers. Braz. Arch. Biol. Technol., 48: 71-77.
CrossRef | Direct Link |
Doyle, A. and J.B. Griffiths, 1998. Cell and Tissue Culture: Laboratory Procedures in Biotechnology. John Wiley and Sons, New York, ISBN: 978-0-471-98255-5, Pages: 352.
Fishbein, D.B., K.M. Yenne, D.W. Dreesen, C.F. Teplis, N. Mehta and D.J. Briggs, 1993. Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: A nationwide prospective study. Vaccine, 14: 1390-1394.
Frazatti-Gallina, N.M., R.L. Paoli, R.M. Moura-Fuches, S.C. Jorge and C.A. Pereira, 2001. Higher production of rabies virus in serum-free medium cell cultures on microcarriers. J. Biotechnol., 92: 67-72.
Frazatti-Gallina, N.M., R.M. Mourao-Fuches, R.L. Paoli, M.L.N. Silvia and C. Miyaki et al., 2004. Vero-cell rabies vaccine produced using serum-free medium. Vaccine, 23: 511-517.
Freshney, R.I., 2005. Culture of Animal Cells: A Manual of Basic Technique. 5th Edn., John Wiley and Sons, Inc., New York.
Genari, C.S., L. Gomes and M. Wada, 1998. Alterations in the growth and adhesion pattern of Vero cells induced by nutritional stress conditions. Cell Biol. Int., 22: 285-294.
Glaser, V. and Bioreactor Fermentor Market Trends, 2009. Vaccine and biopharmaceutical product developments boost technological innovation. Genet. Eng. Biotechnol. News, 29: 1-4.
Direct Link |
Gumusderelioglu, M., E. Aslankaraoglu and S. Gurhan, 2001. Rabies virus production in non-woven polyster fabric (NWPF) packed-bed reactors. Biotechnol. Applied Biochem., 33: 167-172.
Direct Link |
Hassell, T., S. Gleave and M. Butler, 1991. The effect of lactate and ammonia. Applied Biochem. Biotechnol., 30: 29-41.
Hesse, F. and R. Wagner, 2000. Developments and improvements in the manufacturering of human therapeutics with mammalian cell cultures. Tibtech, 18: 173-180.
Hinterkorner, G., G. Brugger, D. Muller, F. Hesse, R. Kunert, H. Katinger and N. Borth, 2007. Improvement of the energy metabolism of recombinant CHO cells by cell sorting for reduced mitochondrial membrane potential. J. Biotechnol., 129: 651-657.
Horaud, F., 1992. Absence of viral sequences in the WHO-Vero cell bank: A collaborative study. Dev. Biol. Stand, 76: 43-46.
Direct Link |
Jagannathan, S., S. Chaansha, K. Rajesh, T. Santhiya, C. Charles and K.N. Venkataramana, 2009. Standardization and assessment of cell culture media quantities in roller poly ethylene terephthalate bottles employed in the industrial rabies viral vaccine production. Pak. J. Biol. Sci., 12: 1246-1252.
CrossRef | Direct Link |
Knobel, D.L., S. Cleaveland, P.G. Coleman, E.M. Fevre and M.I. Meltzer et al., 2005. Re-evaluating the burden of rabies in Africa and Asia. Bull. World Health Organiz., 83: 360-368.
Direct Link |
Kumar, A.A.P., Y.U.B. Rao, A.L.W. Joseph, K.R. Mani and K. Swaminathan, 2002. Process standardization for optimal virus recovery and removal of substrate DNA and bovine serum proteins in Vero cell derived rabies vaccine. J. Biosci. Bioeng., 94: 375-383.
PubMed | Direct Link |
Lubiniecki, A.S., 1999. Elimination of serum from cell culture medium. Dev. Biol. Stand, 99: 153-156.
Direct Link |
Martinzn, L., 2000. Global infectious disease surveillance. Int. J. Infect. Dis., 4: 222-228.
Mendonca, R.Z. and C.A. Periera, 1995. High density Vero cell culture on microcarriers in a cell bioreactor. Bioprocess Biosyst. Eng., 12: 279-282.
Mendonca, R.Z., L.M. Ioshimoto, R.M. Mendonca, M. De-Franco, E.J. Valentini et al., 1993. Preparation of human rabies vaccine in Vero cell culture using a microcarrier system. Braz. J. Med. Biol. Res., 26: 1305-1317.
Merten, O.W., 2000. Safety for vaccine(e)s. Cytotechnology, 34: 181-183.
Merten, O.W., H. Kallel, J.C. Manuguerra, M. Tardy-Panit and R. Crainic et al., 1999. The new medium MDSS2N, free of any animal protein supports cell growth and production of various viruses. Cytotechnology, 30: 191-201.
Merten, O.W., J.V. Kierulff, N. Castignolles and P. Perrin, 1994. Evaluation of the new serum-free medium (MDSS2) for the production of different biological: Use of various cell lines. Cytotechnology, 14: 47-59.
Meslin, F.X., D.B. Fishbein and H.C. Matter, 1994. Rationale and prospects for rabies elimination in developing countries. Curr. Trop. Microbiol. Immunol., 187: 1-26.
Montagnon, B.J., J.C. Vincent-Falquet and J.F. Saluzzo, 1999. Experience with vero cells at pasteur merieux connaught. Dev. Biol. Stand, 98: 137-140.
Direct Link |
Namdev, P.K. and P. Lio, 2000. Assessing a disposable bioreactor for attachment-dependent cell cultures. Bio. Pharm., 13: 44-51.
Direct Link |
Nandi, S. and M. Kumar, 2011. Global perspective of rabies and rabies related viruses: A comprehensive review. Asian J. Anim. Vet. Adv., 6: 101-116.
CrossRef | Direct Link |
New Brunswick Scientific, 2006. Inoculation, growth and harvesting in a new easy-to-use disposable cell culture system. BioTechniques, 4: 1-5.
Direct Link |
Paillet, C., G. Forno, R. Kratje and M. Etcheverrigaray, 2009. Suspension-Vero cell cultures as a platform for viral vaccine production. Vaccine, 27: 6464-6467.
Quesney, S., J. Marvel, A. Marc, C. Gerdil and B. Meignier, 2001. Characterization of Vero cell growth and death in bioreactor with serum-containing and serum-free media. Cytotechnology, 35: 115-125.
Rourou, S., A. Ark, T. Velden and H. Kallel, 2007. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Vaccine, 25: 3879-3889.
Rourou, S., A. ven den Ark, S. Majoul, K. Trabelsi, T. ven den Velden and H. Kallel, 2009. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor. Applied Microbiol. Biotechnol., 85: 53-63.
Smith, J.S., P.A. Yager and G.M. Baer, 1973. A Rapid Tissue Culture Test for Determining Rabies Neutralizing Antibody. In: Laboratory Techniques in Rabies, Kaplan, M.M. and H. Koprowski (Eds.). WHO, Geneva, pp: 354-357.
Trabelsi, K., S. Rourou, H. Loukil, S. Majoul and H. Kallel, 2005. Comparison of virous culture modes for the production of rabies virus by Vero cells grown on microcarriers in a 2-l bioreactor. Enzyme Microb. Technol., 36: 514-519.
Trabelsi, K., S. Rourou, H. Loukil, S. Majoul and H. Kallel, 2006. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. J. Biotechnol., 121: 261-271.
Vincent-Falquest, J.C., L. Peyron, M. Souvras, J.C. Moulin, J. Tektoff and J. Patet, 1989. Qualification of working cell banks for the vero cell line to produce licensed human vaccines. Dev. Biol. Stand, 70: 153-156.
Vyas, R. and J. Cino, 2005. High-yield single-use cell culture systems. Genet. Eng. News, 25: 1-4.
Direct Link |
WHO, 2010. Weekly epidemiological record. Volume 85, No. 32, pp: 309-320. http://www.who.int/wer/en/.
WHO., 2007. Meeting report of WHO study group on cell substrates for production of biologicals. WHO Headquarters, Geneva.
Wentz, D. and l.K. Schiiger, 1992. Influence of lactate, ammonia and osmotic stress on adherent and suspension BHK cells. Enzyme Microb. Technol., 14: 68-75.
Yasumura, Y. and M. Kawakita, 1963. The research for the SV40 by means of tissue culture technique. Nippon Rinsho, 21: 1201-1219.
Yokomizo, A.Y., M.M. Antoniazzi, P.L. Galdino, N. Jr. Azambuja, S.A. Jorge and C.A. Pereira, 2004. Rabies virus production in high vero cell density cultures on macroporous microcarriers. Biotechnol. Bioeng., 85: 506-515.